Blonanserin

Blonanserin

Product Name: Blonanserin

CAS No.: 132810-10-7

Specification and Standard: Internal Control

Package Size: 20kg/Bag

Molecular Formula :C23H30FN3

Indication:

Bunanserin is a new type of atypical antipsychotic drug, which has antagonistic effects on dopamine receptors and 5HT receptors.

It has an antagonistic effect on dopamine receptors, which can antagonize excessive dopamine activity and treat positive symptoms of psychosis, such as hallucinations, delusions, speech and deed disorders, etc.;

It has an antagonistic effect on serotonin receptors in the postsynaptic membrane, which can improve the patient's cognition and emotion, such as relieving the patient's psychiatric negative symptoms such as poor thinking, apathy, and social withdrawal.